Stereotactic Body Radiotherapy ( SBRT ) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma ( SCC )
Head & Neck · 2026-12 · 48 (12) · 3411-3418
DOI: 10.1002/hed.70360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 29.06.2026. Verfasst von Mohammed Aldohan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Radiosurgery, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) in previously untreated primary mucosal head and neck cancer (HNC) patients unfit for conventional radiation therapy. Materials and Methods Retrospective analysis of previously unirradiated primary SCC mucosal HNC patients treated with SBRT from 2011 to 2022.
Results
HN SBRT was prescribed to 74 patients (median age: 81 years [52–97]; 85% ECOG 2–3) with 77 primary tumors (62% oral cavity; 64% T3‐4 disease). A five‐fraction prescription ranging from 35 to 50 Gy (95% received ≥ 40 Gy, 59.7% received ≥ 45 Gy) was delivered twice weekly, with the majority (81%) completing treatment within 14 days and all patients completing treatment. Symptomatic relief was achieved by 84%, including 27.3% with complete symptomatic response. With a median follow‐up of 7.3 months, 1‐year outcomes were 81% local control, 16% regional recurrence rate, and 12% distant metastasis rate. Median progression‐free and overall survival were 6.4 and 8 months, respectively. Acute Grade 3+ toxicity occurred in 36%, primarily mucositis (30%). Late Grade ≥ 3 toxicity was observed in 10% ( n = 7), including osteoradionecrosis in 5 patients, with residual or concurrent disease present in 5% ( n = 4). PTV > 159 cm 3 was significantly correlated with late grade ≥ 3 toxicity (OR = 15.98; p = 0.0041).
Conclusion
High‐dose SBRT may deliver high rates of local control and palliation for primary mucosal HNC patients unfit for conventional radiation, but prospective, comparative, high‐quality data are needed. A randomized trial (NCT06641791) comparing SBRT to conventional palliative RT in the elderly unfit HNC patient is underway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.
- Odette Cancer Centre - Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Mohammed Aldohan, Irene Karam
Zitieren
APA
Aldohan, M., Karam, I., Safavi, A. H., Chin, L., Zhang, L., Gooanratne, E., Galapin, M., Eskander, A., Higgins, K., Enepekides, D., & Poon, I. (2026). Stereotactic Body Radiotherapy ( SBRT ) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma ( SCC ). Head & Neck, 48(12), 3411-3418. https://doi.org/10.1002/hed.70360
Vancouver
Aldohan M, Karam I, Safavi AH, Chin L, Zhang L, Gooanratne E, et al. Stereotactic Body Radiotherapy ( SBRT ) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma ( SCC ). Head & Neck. 2026;48(12):3411-3418. doi:10.1002/hed.70360
BibTeX
@article{Aldohan2026,
author = {Aldohan, Mohammed and Karam, Irene and Safavi, Amir H and Chin, Lee and Zhang, Liying and Gooanratne, Ethan and Galapin, Madette and Eskander, Antoine and Higgins, Kevin and Enepekides, Danny and Poon, Ian},
title = {Stereotactic Body Radiotherapy ( SBRT ) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma ( SCC )},
journal = {Head & Neck},
year = {2026},
volume = {48},
number = {12},
pages = {3411--3418},
doi = {10.1002/hed.70360}
}
EUVIMED